Samuel Sears

Samuel Sears

Director/Board Member at HEDGEPATH PHARMACEUTICALS INC

Net worth: 107 482 $ as of 2026-05-30

82 year
Health Technology
Commercial Services
Retail Trade

Profile

Currently, Samuel P.
Sears
serves as Independent Director at Inhibitor Therapeutics, Inc. since 2022 and as Of Counsel at Cetrulo & Capone LLP since 2019.
Formerly, the roles include Chairman & Chief Executive Officer at Rock Creek Pharmaceuticals, Inc. in 1998, Vice Chairman at American Prescription Providers, Inc. in 1999, Director at Independent Bank Corp.
(Michigan), Independent Director at Commonwealth Biotechnologies, Inc. from 2011 to 2013, Independent Director at BioDelivery Sciences International, Inc. from 2011 to 2018, Director at The Casual Male, Inc., Independent Director at Inhibitor Therapeutics, Inc. from 2013 to 2016, and Managing Partner at Burns & Levinson LLP from 1981 to 1993.
Education includes graduate studies at Boston College Law School and undergraduate studies at Harvard College.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2025-03-31 1,279,543 ( 0.74% ) 107 482 $ 2026-05-30

Samuel Sears active positions

CompaniesPositionStart
HEDGEPATH PHARMACEUTICALS INC Director/Board Member 2022-12-12
General Counsel 2018-12-31

Former positions of Samuel Sears

CompaniesPositionEnd
BIODELIVERY SCIENCES INTERNATIONAL, INC. Director/Board Member 2018-05-20
HEDGEPATH PHARMACEUTICALS INC Director/Board Member 2016-11-29
Director/Board Member 2013-08-18
Director/Board Member 1999-01-31
ROCK CREEK PHARMACEUTICALS, INC. Chief Executive Officer 1998-04-30
See the detail of Samuel Sears's experience

Training of Samuel Sears

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

50

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Finance

Commercial Services

Health Technology

Health Technology

Retail Trade

Commercial Services

Commercial Services

Retail Trade

Health Technology

Consumer Services

Consumer Services

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!